ROCKVILLE, Md.--(BUSINESS WIRE)--Innovative Biosensors, Inc. (IBI), a company developing rapid, ultra-sensitive tests to detect harmful pathogens for both the biodefense and clinical infectious disease markets, and Thermo Fisher Scientific, Inc., the world leader in serving science, announced today that they had entered into a manufacturing and distribution agreement.
